Advertisement
Advertisement

DMRA

DMRA logo

Damora Therapeutics, Inc. Ordinary Shares

29.92
USD
Sponsored
+0.04
+0.13%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

29.94

+0.02
+0.07%

Damora Therapeutics, Inc. Ordinary Shares Profile

About

Damora Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company is engaged in the advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms. Damora Therapeutics Inc., formerly known as Galecto Inc, is based in Denmark.

Info & Links

CEO

Carl Goldfischer

Headquarters

221 Crescent Street Building 23, Suite 105
Boston, MA 02109, DENMARK

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.galecto.com

Auditor

EY Godkendt Revisionspartnerselskab

Share holders

36

Employees

7

Damora Therapeutics, Inc. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

1.84B

Enterprise Value

1.31B

Enterprise Value/EBITDA(ttm)

-5.48

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.75

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-428.30%

Return on Invested Capital(ttm)

-159.45%

Return on Assets(ttm)

-114.62%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-239.06M

Net Income Available to Common(ttm)

-24.22M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.47

52-Week Change

--

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

61.55M

Dividend Yield

0.00%

Float4

61.31M

% Held by Insiders

0.40%

% Held by Institutions

14.20%

Balance Sheet

Total Cash(mrq)

532.90M

Total Cash Per Share(mrq)

8.66

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

22.48%

Quick Ratio(mrq)

22.48%

Book Value Per Share(mrq)

8.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.60

Free Cash Flow(ytd)

-20.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement